Dipo Olowookere
By Dipo Olowookere
United States Global AIDS Coordinator and Special Representative for Global Health Diplomacy, Ambassador Deborah Birx, on April 25, approved PEPFAR’s $483 million Country Operational Plan 2017 (COP2017) budget for South Africa, an increase over 2016.
The COP2017 budget will support South Africa’s HIV/AIDS and tuberculosis (TB) programs through September 2018.
The US President’s Emergency Plan for AIDS Relief (PEPFAR) is the American government’s initiative to help save the lives of those infected with and affected by HIV/AIDS around the world. Since 2004, PEPFAR has invested over $5.6 billion in South Africa’s response to prevent and treat HIV/AIDS and TB. This investment has saved the lives of millions of South Africans.
With this new funding allocation, the U.S. Embassy in Pretoria, through PEPFAR, will continue programs in support of South Africa’s HIV/AIDS and TB response under the recently launched 2017-2022 HIV, TB, and Sexually Transmitted Infections (STIs) National Strategic Plan (NSP). An additional $51 million in funding to support South Africa’s voluntary male medical circumcision program may be available based upon program performance.
Speaking at the PEPFAR COP2017 Review, Dr Yogan Pillay, the National Department of Health’s Deputy Director General: HIV/AIDS, TB and Maternal, Child and Women’s Health said, “I wish to thank the US government for its continued support of our country’s response to the HIV and TB epidemics under its PEPFAR program.
“Given the scale of the challenges that we face, it is unlikely that the progress we have made would have been possible without its support, and neither will we be able to achieve the targets in the National Strategic Plan.” Senior U.S. and South African government health officials and civil society attended the session.
Ambassador Birx acknowledged South Africa’s leadership, commitment and substantial funding of the national HIV response, and highlighted the need for continued use of data, improved approaches, and rigorous program management.
South Africa funds more than 80% of its national HIV response, which currently provides lifesaving care and treatment to more than 3.7 million persons living with HIV (PLHIV). PEPFAR funding supports national and provincial programs focused on the 27 highest HIV-burdened districts in eight provinces. These 27 districts represent more than 80 percent of South Africa’s PLHIV.
From October 2017 through September 2018, PEPFAR will continue to assist South Africa in providing more than one million additional PLHIV with lifesaving treatment, for a total of 4.3 million on treatment in the 27 focus districts. These ambitious goals require the work and commitment of all stakeholders and reflect the goals of the NSP to have more than 90 percent of the estimated seven million South Africans on treatment.
